Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Smolen

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Annals of the Rheumatic Diseases|January 28, 2025
Greetings from the Editor - 2025Josef Smolen
Arthritis Research|July 12, 2002
Autoantibodies in rheumatoid arthritis and their clinical significanceGünter Steiner, Josef Smolen
International Archives of Allergy and Immunology|March 15, 2002
Treatment of rheumatoid arthritis by TNF-blocking agentsWinfried Graninger, Josef Smolen
Nature Clinical Practice. Rheumatology|May 22, 2008
Is computer-assisted management necessary for patients with early rheumatoid arthritis?Daniel Aletaha, Josef Smolen
Seminars in Arthritis and Rheumatism|June 11, 2015
Biosimilar safety factors in clinical practiceWalter Reinisch, Josef Smolen
Rheumatology (Oxford, England)|June 22, 2012
Rheumatoid arthritis: where are we now?Josef Smolen, Edward C Keystone
Rheumatology (Oxford, England)|June 22, 2012
Future of RA: building on what we know and tailoring treatmentJosef Smolen, Edward C Keystone
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 22, 2007
Patient access to rheumatoid arthritis treatmentsBengt Jönsson, Gisela Kobelt, Josef Smolen
Annals of the Rheumatic Diseases|April 6, 2016
Response to: 'Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update' by Goswami et alTanja Stamm, Michaela Stoffer, Josef Smolen
Arthritis Research & Therapy|June 21, 2015
Response to 'Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis'Nathan Vastesaeger, Bruno Fautrel, Josef Smolen
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Annals of the Rheumatic Diseases|January 28, 2025
Greetings from the Editor - 2025Josef Smolen
Arthritis Research|July 12, 2002
Autoantibodies in rheumatoid arthritis and their clinical significanceGünter Steiner, Josef Smolen
International Archives of Allergy and Immunology|March 15, 2002
Treatment of rheumatoid arthritis by TNF-blocking agentsWinfried Graninger, Josef Smolen
Nature Clinical Practice. Rheumatology|May 22, 2008
Is computer-assisted management necessary for patients with early rheumatoid arthritis?Daniel Aletaha, Josef Smolen
Seminars in Arthritis and Rheumatism|June 11, 2015
Biosimilar safety factors in clinical practiceWalter Reinisch, Josef Smolen
Rheumatology (Oxford, England)|June 22, 2012
Rheumatoid arthritis: where are we now?Josef Smolen, Edward C Keystone
Rheumatology (Oxford, England)|June 22, 2012
Future of RA: building on what we know and tailoring treatmentJosef Smolen, Edward C Keystone
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 22, 2007
Patient access to rheumatoid arthritis treatmentsBengt Jönsson, Gisela Kobelt, Josef Smolen
Annals of the Rheumatic Diseases|April 6, 2016
Response to: 'Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update' by Goswami et alTanja Stamm, Michaela Stoffer, Josef Smolen
Arthritis Research & Therapy|June 21, 2015
Response to 'Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis'Nathan Vastesaeger, Bruno Fautrel, Josef Smolen
Pageof 10